L. Ebony Boulware to Lead the Wake Forest University School of Medicine

L. Ebony Boulware was named the next dean of the School of Medicine at Wake Forest University in Winston-Salem, North Carolina. She will also serve as vice chief academic officer and chief science officer of Atrium Health. Dr. Boulware will begin her new duties on January 1.

“I am deeply honored and thrilled to join Wake Forest University School of Medicine and Atrium Health at this transformational time to advance a vision for improving health and health equity through our educational, research, and clinical missions,” Dr. Boulware said.

Dr. Boulware has been serving as the director of the Duke Clinical and Translational Science Institute, in Durham, North Carolina, and as vice dean for translational science and associate vice chancellor for translational research at Duke University. She has served as a distinguished professor of medicine and as chief of the division of general internal medicine in the department of medicine at the Duke University School of Medicine.

Dr. Boulware is a general internist, physician-scientist and clinical epidemiologist focused on improving health and health equity for individuals and communities affected by chronic health conditions such as kidney disease. She is a member of the National Academy of Medicine and the American Academy of Arts and Sciences.

Dr. Boulware received her bachelor’s degree in English from Vassar College in Poughkeepsie, New York, and her medical degree from Duke University School of Medicine. She completed her residency and chief residency at the University of Maryland prior to completing a research fellowship in general internal medicine at Johns Hopkins University, where she earned a master’s degree in public health from Johns Hopkins Bloomberg School of Public Health.


Leave a Reply

Due to incidents of abuse and harassment that have occurred in the past, JBHE will not publish telephone numbers or email addresses of individuals in this space. If you want to contact someone in a particular article, we suggest you contact them directly not in an open forum.